SMARCA1 and rhabdoid tumor: Malignant rhabdoid tumors caused by the loss of hSNF5 exhibit aberrant SWI/SNF complex functions, which result in abnormal gene expression, and molecular‐targeted therapy may be applied to the affected pathway.